|
"蔡育傑"的相关文件
显示项目 1-25 / 27 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T09:13:59Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Chuang, Yuan-Ting; YEONG-SHIAU PU; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chen, You-Tzung; Huang, K.-H. and Kuo, K.-L. and Chen, S.-C. and Weng, T.-I. and Chuang, Y.-T. and Tsai, Y.-C. and Pu, Y.-S. and Chiang, C.-K. and Liu, S.-H.; Huang, Kuo-How;Kuo, Kuan-Lin;Chen, Shyh-Chyan;Weng, Te-I;Chuang, Yuan-Ting;Tsai, Yu-Chieh;Pu, Yeong-Shiau;Chiang, Chih-Kang;Liu, Shing-Hwa; 蒲永孝;劉興華;蔡育傑;姜至剛;陳世乾;翁德怡;黃國皓; TE-I WENG; CHIH-KANG CHIANG; YU-CHIEH TSAI; Kuo, Kuan-Lin; Chen, Shyh-Chyan; SHING-HWA LIU; KUO-HOW HUANG |
| 國立臺灣大學 |
2016 |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu, Feng-Ming; Hou, Wei-Hsien; Huang, Chao-Yuan; Wang, Chia-Chun; Tsai, Chiao-Ling; Tsai, Yu-Chieh; Yu, Hong-Jeng; Pu, Yeong-Shiau; Cheng, Jason Chia-Hsien; 蒲永孝; 余宏政; 成佳憲; 王嘉檇; 蔡育傑; 黃昭淵; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2015 |
利用新一代EGFR酪氨酸激?抑制劑為放射增敏劑，用於膀胱癌的治療
|
蔡育傑; Tsai, Yu-Chieh |
| 國立臺灣大學 |
2015 |
Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
|
Hu, Che-Yuan; Tsai, Yu-Chieh; Wang, Shuo-Meng; Huang, Chao-Yuan; Tai, Huai-Ching; Chen, Chung-Hsin; Pu, Yeong-Shiau; Lin, Wei-Chou; Huang, Kuo-How; 戴槐青; 蒲永孝; 陳忠信; 蔡育傑; 黃昭淵; 林維洲; 黃國皓; 王碩盟 |
| 國立臺灣大學 |
2015 |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo, Kuan-Lin; Ho, I-Lin; Shi, Chung-Sheng; Wu, June-Tai; Lin, Wei-Chou; Tsai, Yu-Chieh; Chang, Hong-Chiang; Chou, Chien-Tso; Hsu, Chen-Hsun; Hsieh, Ju-Ton; Chang, Shih-Chen; Pu, Yeong-Shiau; Huang, Kuo-How; 蒲永孝; 張宏江; 吳君泰; 蔡育傑; 林維洲; 黃國皓; 謝汝敦 |
| 國立臺灣大學 |
2015 |
MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma
|
Ho, I-Lin; Kuo, Kuan-Lin; Shing-Hwa-Liu; Chang, Hong-Chiang; Hsieh, Ju-Ton; Wu, June-Tai; Chiang, Chih-Kang; Lin, Wei-Chou; Tsai, Yu-Chieh; Chou, Chien-Tso; Hsu, Chen-Hsun; Pu, Yeong-Shiau; Shi, Chung-Sheng; Huang, Kuo-How; 蒲永孝; 張宏江; 吳君泰; 蔡育傑; 林維洲; 姜至剛; 黃國皓; 謝汝敦 |
| 國立臺灣大學 |
2015 |
Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells
|
Tsai, Yu-Chieh; Ho, Pei-Yin; Tzen, Kai-Yuan; Tuan, Tsung-Fan; Liu, Wei-Lin; Cheng, Ann-Lii; Pu, Yeong-Shiau; Cheng, Jason Chia-Hsien; 蒲永孝; 曾凱元; 鄭安理; 成佳憲; 蔡育傑; 何蓓茵 |
| 國立臺灣大學 |
2014 |
Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126
|
Tai, Huai-Ching; Chang, An-Chen; Yu, Hong-Jeng; Huang, Chao-Yuan; Tsai, Yu-Chieh; Lai, Yu-Wei; Sun, Hui-Lung; Tang, Chih-Hsin; Wang, Shih-Wei; 戴槐青; 余宏政; 蔡育傑; 黃昭淵 |
| 國立臺灣大學 |
2013 |
Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: A planning and feasibility study
|
Tsai, Yi-Chun; Tsai, Chiao-Ling; Hsu, Feng-Ming; Wu, Jian-Kuen; Wu, Chien-Jang; Cheng, Jason Chia-Hsien; 成佳憲; 蔡育傑; 蔡巧琳; 許峰銘; 吳簡坤 |
| 國立臺灣大學 |
2013 |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai, Yu-Chieh; Yeh, Chih-Hsien; Tzen, Kai-Yuan; Ho, Pei-Yin; Tuan, Tsung-Fan; Pu, Yeong-Shiau; Cheng, Ann-Lii; Cheng, Jason Chia-Hsien; 蒲永孝; 曾凱元; 鄭安理; 成佳憲; 蔡育傑; 何蓓茵 |
| 國立臺灣大學 |
2013 |
Comparison of afatinib and erlotinib as radiosensitizing agents in bladder cancer cells
|
Tsai, Yu-Chieh; Tuan, Tsung-Fan; Ho, Pei-Yin; Liu, Wei-Lin; Chang, Liang-Yu; Pu, Yeong-Shiau; Cheng, Ann-Lii; Chen, Jason Chia-Hsien; 蒲永孝; 鄭安理; 成佳憲; 蔡育傑; 何蓓茵 |
| 國立臺灣大學 |
2012 |
Changes of Pulmonary Fluorodeoxyglucose Uptake After Neoadjuvant Concurrent Chemoradiation in Predicting Postoperative Pulmonary Complications for Patients With Esophageal Cancer
|
Hsu, F.; Cheng, J.; Lee, J.; Huang, P.; Hsu, C.; Lin, C.; Tsai, Y.; Tzen, K.; Yen, R.; 曾凱元; 成佳憲; 顏若芳; 蔡育傑; 許駿; 李章銘; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
Down-regulation of PKC zeta in renal cell carcinoma and its clinicopathological implications
|
Pu, Yeong-Shiau; Huang, Chao-Yuan; Chen, Jyue-Yu; Kang, Wang-Yi; Lin, Ying-Chu; Shiu, Yu-Shiang; Chuang, Shu-Ju; Yu, Hong-Jeng; Lai, Ming-Kuen; Tsai, Yu-Chieh; Wu, Wen-Jeng; Hour, Tzyh-Chyuan; 蒲永孝; 余宏政; 賴明坤; 蔡育傑; 黃昭淵 |
| 國立臺灣大學 |
2012 |
Down-Regulation of Glucose-Regulated Protein (GRP) 78 Potentiates Cytotoxic Effect of Celecoxib in Human Urothelial Carcinoma Cells
|
Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Weng, Te-I; Chuang, Yuan-Ting; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chiang, Chih-Kang; Liu, Shing-Hwa; 蒲永孝; 劉興華; 蔡育傑; 姜至剛; 陳世乾; 翁德怡; 黃國皓 |
| 國立臺灣大學 |
2010 |
Gene Expression Differences of Peripheral Blood Cells Predict Pathological Complete Response to Neoadjuvant Concurrent Chemoradiation in Patients with Esophageal Squamous Cell Carcinoma
|
許峰銘; 李元麒; 李章銘; 林家齊; 蔡育傑; 成佳憲; HSU, FENG-MING; LEE, YUNG-CHIE; LEE, JANG-MING; LIN, CHIA-CHI; TSAI, YU-CHIEH; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Vmat for Prostate Cancer: Superior Organ Sparing to Imrt and Delivery Efficiency to Helical Tomotherapy
|
成佳憲; 吳簡坤; 蔡巧琳; 趙曉玲; 蔡育傑; CHENG, JASON CHIA-HSIEN; WU, JIAN-KUEN; TSAI, CHIAO-LING; CHAO, HSIAO-LING; TSAI, YU-CHIEH |
| 國立臺灣大學 |
2009 |
Downregulation of Abcd1 in Human Renal Cell Carcinoma
|
侯自銓; 郭怡孜; 劉光耀; 康婉儀; 黃昭淵; 蔡育傑; 吳文正; 黃書彬; 蒲永孝; HOUR, TZYH-CHYUAN; KUO, YI-ZIH; LIU, GUANG-YAW; KANG, WANG-YI; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; WU, WEN-JENG; HUANG, SHU-PIN; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2009 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Intensity- Modulated Radiation Therapy and Concurrent Chemotherapy Followed by Thoracic Esophagectomy
|
許峰銘; 李元麒; 李章銘; 徐志宏; 林家齊; 蔡育傑; 吳簡坤; 成佳憲; HSU, FENG-MING; LEE, YUNG-CHIE; LEE, JANG-MING; HSU, CHIH-HUNG; LIN, CHIA-CHI; TSAI, YU-CHIEH; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Dosimetric and/or Treatment Advantages of Vmat to Imrt and Helical Tomotherapy in Prostate Cancer
|
蔡巧琳; 吳簡坤; 蔡育傑; 趙曉玲; 成佳憲; TSAI, CHIAO-LING; WU, JIAN-KUEN; TSAI, YU-CHIEH; CHAO, HSIAO-LING; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy with/ without Esophagectomy for Locally Advanced Esophageal Squamous Cell Carcinoma
|
林家齊; 成佳憲; 李章銘; 蔡育傑; 許峰銘; 李元麒; 鄭安理; LIN, CHIA-CHI; CHENG, JASON CHIA-HSIEN; LEE, JANG- MING; TSAI, YU-CHIEH; HSU, FENG-MING; LEE, YUNG- CHIE; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
林家齊; 徐志宏; 成佳憲; 黃昭淵; 蔡育傑; 許峰銘; 黃國皓; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHENG, JASON CHIA- HSIEN; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; HSU, FENG -MING; HUANG, KUO-HOW; CHENG, ANN-LII; PU, YEONG- SHIAU |
| 國立臺灣大學 |
2008 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complication in Esophageal Cancer Patients Receiving Intensity Modulated Radiation Therapy Followed by Esophagectomy
|
許峰銘; 吳簡坤; 李元麒; 李章銘; 林家齊; 徐志宏; 蔡育傑; 成佳憲; HSU, FENG-MING; WU, JIAN-KUEN; LEE, YUNG-CHIE; LEE, JANG-MING; LIN, CHIA-CHI; HSU, CHIH-HUNG; TSAI, YU-CHIEH; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Improved Local Control by Surgery and Paclitaxel-Based Chemoradiation for Esophageal Squamous Cell Carcinoma: Results of a Retrospective Non- Randomized Study
|
許峰銘; 林家齊; 李章銘; 張逸良; 徐志宏; 蔡育傑; 李元麒; 成佳憲; HSU, FENG-MING; LIN, CHIA-CHI; LEE, JANG-MING; CHANG, YIH-LEONG; HSU, CHIH-HUNG; TSAI, YU-CHIEH; LEE, YUNG-CHIE; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2007 |
Stopping Smoking Might Reduce Tumour Recurrence in Nonmuscle-Invasive Bladder Cancer
|
陳忠信; 孫家棟; 黃國皓; 黃昭淵; 蔡育傑; 余宏政; 蒲永孝; CHEN, CHUNG-HSIN; SHUN, CHIA-TUNG; HUANG, KUO-HOW; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; YU, HONG-JENG; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2007 |
Gemcitabine and Ifosfamide as a Second-Line Treatment for Cisplatin- Refractory Metastatic Urothelial Carcinoma: A Phase Ii Study
|
林家齊; 徐志宏; 黃昭淵; 耿孝宜; 蔡育傑; 黃國皓; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; HUANG, CHAO-YUAN; KENG, HSIAO-YI; TSAI, YU-CHIEH; HUANG, KUO-HOW; CHENG, ANN-LII; PU, YEONG-SHIAU |
显示项目 1-25 / 27 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
